Analyst surprised by Lundbeck announcement
The recent downgrading of expectations in Lundbeck is largely due to factors which no one could have anticipated when expectations were set following the patent cliff. But could the pharmaceutical group have informed investors about factors affecting the bottom line earlier on, one analyst wonders?
by Leonora Beck
It came as a great surprise to Sydbank analyst Søren Løntoft Hansen when Lundbeck lowered expectations for the financial years 2013 and 2014 this Wednesday morning.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
New expectations make the Lundbeck share plummet
For abonnenter
Sydbank: A positive signal
For abonnenter
